Literature DB >> 11325858

N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells.

G Li1, K Satyamoorthy, M Herlyn.   

Abstract

During melanoma development, loss of functional E-cadherin accompanies gain of expression of N-cadherin. The present study was carried out to investigate the functional significance of N-cadherin in melanoma cells. N-Cadherin mediated homotypic aggregation among melanoma cells as well as heterotypic adhesion of melanoma cells to dermal fibroblasts and vascular endothelial cells. Blocking of N-cadherin-mediated intercellular interaction by N-cadherin-specific antibodies increased the number of cells undergoing apoptosis. N-Cadherin-mediated cell adhesion-activated antiapoptotic protein Akt/PKB and subsequently increased beta-catenin and inactivated the proapoptotic factor BAD: Furthermore, N-cadherin promoted migration of melanocytic cells over dermal fibroblasts, suggesting that N-cadherin may also play a role in metastasis. Together, these results indicate that the cadherin subtype switching from E- to N-cadherin during melanoma development not only frees melanocytic cells from the control by keratinocytes but also provides growth and possibly metastatic advantages to melanoma cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325858

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  148 in total

1.  Cadherin 6B induces BMP signaling and de-epithelialization during the epithelial mesenchymal transition of the neural crest.

Authors:  Ki-Sook Park; Barry M Gumbiner
Journal:  Development       Date:  2010-07-07       Impact factor: 6.868

2.  Effects of blocking integrin β1 and N-cadherin cellular interactions on mechanical properties of vascular smooth muscle cells.

Authors:  Aesha Desai; Sandra Geraghty; Delphine Dean
Journal:  J Biomech       Date:  2018-11-22       Impact factor: 2.712

3.  Fibroblasts contribute to melanoma tumor growth and drug resistance.

Authors:  Edward H Flach; Vito W Rebecca; Meenhard Herlyn; Keiran S M Smalley; Alexander R A Anderson
Journal:  Mol Pharm       Date:  2011-11-08       Impact factor: 4.939

4.  ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling.

Authors:  Karina Reiss; Thorsten Maretzky; Andreas Ludwig; Thomas Tousseyn; Bart de Strooper; Dieter Hartmann; Paul Saftig
Journal:  EMBO J       Date:  2005-02-03       Impact factor: 11.598

5.  Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway.

Authors:  Jianfei Qi; Ning Chen; Junfu Wang; Chi-Hung Siu
Journal:  Mol Biol Cell       Date:  2005-06-29       Impact factor: 4.138

Review 6.  Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application.

Authors:  Carrie W Rinker-Schaeffer; James P O'Keefe; Danny R Welch; Dan Theodorescu
Journal:  Clin Cancer Res       Date:  2006-07-01       Impact factor: 12.531

7.  Pigment epithelium-derived factor blocks tumor extravasation by suppressing amoeboid morphology and mesenchymal proteolysis.

Authors:  Omar Ladhani; Cristina Sánchez-Martinez; Jose L Orgaz; Benilde Jimenez; Olga V Volpert
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

8.  N-cadherin expression is a potential survival mechanism of gefitinib-resistant lung cancer cells.

Authors:  Mai Yamauchi; Ikuyo Yoshino; Rui Yamaguchi; Teppei Shimamura; Masao Nagasaki; Seiya Imoto; Atsushi Niida; Fumiaki Koizumi; Takashi Kohno; Jun Yokota; Satoru Miyano; Noriko Gotoh
Journal:  Am J Cancer Res       Date:  2011-08-08       Impact factor: 6.166

9.  Opposite roles of furin and PC5A in N-cadherin processing.

Authors:  Deborah Maret; Mohamad Seyed Sadr; Emad Seyed Sadr; David R Colman; Rolando F Del Maestro; Nabil G Seidah
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

Review 10.  The role of altered cell-cell communication in melanoma progression.

Authors:  Nikolas K Haass; Keiran S M Smalley; Meenhard Herlyn
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.